Share ownership Thermo Fisher Scientific, Inc.

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 08/05/2026 BST			5-day change	1st Jan Change
465.00 ^USD	-1.99%		-0.90%	-19.75%

05-04	Thermo Fisher Scientific Inc. Introduces Gibco CTS DynaXS Single Use Bioreactor	CI
05-04	Applied BioCode Announces FDA Clearance for KingFisher? Nucleic Acid Extraction with BioCode® Respiratory Pathogen Panel for IVD Use	CI

Share class: Thermo Fisher Scientific, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	445,473,074	370,983,025 ( 83.28 %)	73,851,609 ( 16.58 %)	83.28 %

Major shareholders: Thermo Fisher Scientific, Inc.

Name	Equities	%	Valuation
Vanguard Capital Management LLC (Pennsylvania) 6.536 %	24,280,816	6.536 %	11 935 M $
BlackRock Advisors LLC 5.622 %	20,883,304	5.622 %	10 265 M $
STATE STREET CORPORATION 4.472 %	16,613,761	4.472 %	8 166 M $
Eaton Vance Management 3.202 %	11,894,277	3.202 %	5 846 M $
Capital Research & Management Co. (World Investors) 2.962 %	11,003,814	2.962 %	5 409 M $
Fidelity Management & Research Co. LLC 2.635 %	9,787,642	2.635 %	4 811 M $
Geode Capital Management LLC 2.206 %	8,196,477	2.206 %	4 029 M $
T. Rowe Price International Ltd. 2.073 %	7,701,353	2.073 %	3 785 M $
BlackRock Life Ltd. 1.955 %	7,261,510	1.955 %	3 569 M $
JPMorgan Investment Management, Inc. 1.78 %	6,611,878	1.78 %	3 250 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Western Asset Management Company DTVM Ltda. 0.002095 %	374,198	0.002095 %	4 M $
Safra Asset CTVM SA (Investment Management) 0.000242 %	43,300	0.000242 %	440 881 $

Breakdown by shareholder type

Institutional	73.3%
Other	12.18%
State Street Corp.	4.47%
Manulife Financial Corp.	0.41%
Swedbank AB	0.4%
Schweizerische Nationalbank	0.3%
Sumitomo Mitsui Trust Group, Inc.	0.29%
Rathbones Group Plc	0.25%
Governments	0.14%
Individuals	0.12%
Fifth Third Bancorp	0.11%
Menora Mivtachim Holdings Ltd.	0.08%
SEI Investments Co.	0.07%
Danske Bank A/S	0.07%
The Bank of Nova Scotia	0.03%
Regions Financial Corp.	0.02%
Commerzbank AG	0.02%
Polar Capital Holdings Plc	0.02%
Silvercrest Asset Management Group, Inc.	0.02%
Markel Group, Inc.	0.02%
Münchener Rückversicherungs-Gesellschaft AG	0.02%
Zurich Insurance Group AG	0.02%
Peapack-Gladstone Financial Corp.	0.01%
Associated Banc-Corp	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Banco Bilbao Vizcaya Argentaria SA	0.01%
Univest Financial Corp.	0.01%
The Allstate Corp.	0.01%
ING Groep NV	0.01%
Unknown	7.57%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	61.18%
United Kingdom	12.5%
Canada	5.22%
Germany	2.08%
Norway	1.66%
France	1.37%
Switzerland	1.33%
Japan	1.2%
Sweden	1.2%
Netherlands	0.79%
Australia	0.65%
Denmark	0.56%
Liechtenstein	0.53%
Singapore	0.29%
South Korea	0.29%
Hong Kong	0.21%
Luxembourg	0.19%
Ireland	0.18%
Belgium	0.17%
Italy	0.15%
Brazil	0.12%
Individuals	0.12%
Israel	0.08%
Finland	0.07%
Spain	0.07%
New Zealand	0.06%
Croatia	0.04%
Czech Republic	0.03%
Austria	0.03%
South Africa	0.02%
Taiwan	0.01%
Slovenia	0.01%
Mexico	0.01%
Puerto Rico	0.01%
China	0.01%

Based on 1000 largest holdings

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (73.2%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - scientific analysis equipments (16.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.; - diagnostics equipment and products (10.1%). Net sales break down by source of revenue between sales of products (58.4%) and services (41.6%). Net sales break down geographically as follows: North America (52.5%), Europe (25.3%), Asia/Pacific (18.6%) and other (3.6%).

Employees

125,000

Sector

Advanced Medical Equipment & Technology

More about the company